Pharmaceutical industry
Turkish firm announces new product for virus treatment
A leading Turkish pharmaceutical firm announced on April 3 that it had successfully made a product "observed to be able to give positive results" in the treatment of the novel coronavirus.
About 30 Antiviral Drugs are being Tested for the Treatment of COVID-19
About 30 antiviral drugs are being tested by innovative pharmaceutical companies to determine if they are effective in treating patients with COVID-19, the Association of Research Pharmaceutical Manufacturers said.
French Scientists Report Successful Results from a COVID-19 Drug Combination
French scientists report successful results from a clinical trial of the combination of two existing drugs - hydroxychloroquine and azithromycin - against the new coranovirus. Their research has been published in the International Journal of Antimicrobial Agents.
Pharmaceutical Industry Promises Affordable Vaccine against COVID-19 no Later than 18 Months
Multinational pharmaceutical companies have committed themselves today to deliver the vaccine against COVID-19 worldwide in 12 to 18 months, AFP reported.
The Coronavirus is Threatening the Global Supply of Antibiotics
The world may face a shortage of antibiotics if the problems of the pharmaceutical industry triggered by the coronavirus epidemic in China are not resolved, Reuters reported.
The agency cites Jörg Wuttke, chairman of the EU Chamber of Commerce in China, at a roundtable in Beijing today.
Pharma giant Sanofi charged in misuse of epilepsy drug
Sanofi, one of France's largest pharmaceutical companies, is being charged by French prosecutors for its failure to fully inform the public and causing harm with its epilepsy drug Depakine.
The UN to Reduce the “Overly Expensive" Price of Insulin
The World Health Organization has announced a scheme to reduce the "overly expensive" price of insulin, BNR reported, citing the BBC. The UN agency wants pharmaceutical companies to produce generic versions of the insulin that it will then test.
Since its discovery in 1923, in America, the price of insulin has risen from $ 1 per vial to about $ 300.
Clawback to rise 41 pct this year
Pharmaceutical companies are set for a far greater burden this year due to the size of the dreaded "clawback" - i.e. the cash they will have to return to the state - according to projections by the National Organization for the Provision of Healthcare Services (EOPYY).
- Read more about Clawback to rise 41 pct this year
- Log in to post comments
Committee to start examining merit of claims Novartis affair was fabricated
A special parliamentary committee that will be inquiring into the merit of claims of political interference in the Novartis bribery case is set to start choosing witnesses on Tuesday afternoon.
Pfizer selects Thessaloniki for a new digital hub
Multinational pharmaceutical company Pfizer has chosen Thessaloniki for the creation of one of its six digital laboratories, aimed at capitalizing on technologies such as artificial intelligence and big data analytics for the development of new treatments.
- Read more about Pfizer selects Thessaloniki for a new digital hub
- Log in to post comments